Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702540 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
The present study suggested that the elevated serum ANGPTL4 level might be a novel diagnostic and prognostic biomarker for patients with RCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Dong Ph.D., M.D., Li M.M., Yunli Ph.D., M.D., Li Ph.D., M.D., Juan Ph.D., M.D., Jun Ph.D., M.D.,